DJIA 16,424.85 0.00 0.00%
NASDAQ 4,086.23 0.00 0.00%
S&P 500 1,862.31 0.00 0.00%
market minute promo

0.00 0.00 (0.00%)

Quote as of


company name or ticker

Recent Quotes

PRX 0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open 0.00
Previous Close 0.00
Daily Range 0.00 - 0.00
52-Week Range 0.00 - 0.00
Market Cap 0.0000
P/E Ratio 0.00
Dividend (Yield) 0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS 4.05

Sector

Healthcare

Industry

Drugs

Par Pharmaceutical Companies, Inc. (PRX) Description

The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States. Website:

News & Commentary Rss Feed

This Amarin Bear Is Throwing In The Towel

Amarin's Problems Just Went From Bad To Worse

Par Pharmaceutical's CEO Discusses 2Q 2013 Results - Earnings Call Transcript

Small-Cap Biotechs with Blockbuster Potential: Hugh Cleland

Par Pharmaceutical Companies Management Discusses Q4 2012 Results - Earnings Call Transcript

A Generic Double Whammy

Teva's sales are hurt by generic competition and lost sales of its own generics.

A Brief Bounce for This Biotech

Horizon Pharmaceuticals enjoys a short-lived bounce following Q3 results.

Wild-Eyed Optimism About Horizon's Plummet

Horizon Pharma's big one-day drop could mean good news.

ADT, Pentair to Gain Spots on S&P 500, Replacing Lexmark, DeVry

New Issue-Par Pharmaceutical sells $490 mln notes

See More PRX News...

PRX's Top Competitors

PRX 0.00 (0.00%)
Current stock: PRX
JNJ $98.75 (0.00%)
Current stock: JNJ
NVS $84.41 (0.00%)
Current stock: NVS
RHHBY $36.17 (0.00%)
Current stock: RHHBY